RNA / Pharmaceutical / Drugs / Neurology / Drug / Pharmaceuticals / Boston / Boston blog main / Boston top stories / National blog main / National top stories / San Diego blog main / San Diego top stories / aducanumab / Alzheimer's disease / Amyotrophic Lateral Sclerosis / AveXis / Barclays / Biogen / deals / Gene Therapy / Geoff Meachem / Ionis Pharmaceuticals / Life Sciences / Michael Ehlers / Michel Vounatsos / Neurological Diseases / Novartis / nusinersen / Spinal Muscular Atrophy / Spinraza / Stroke

Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs

Posted on: Apr 20, 2018   |   Posted by: Biotech Mag

Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs

Biogen will pay Ionis Pharmaceuticals $1 billion to expand their current partnership, doubling down on the RNA drugmaking technology that brought the spinal muscular atrophy...

Continue reading ...